Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Kidney Tumor
- Sponsor
- NYU Langone Health
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Knowledge Score
- Status
- Recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.
- •Patients scheduled for standard-of-care clinical exams with the NYU Urology Department
Exclusion Criteria
- •Stage IV cancer of any type
- •Inability to provide informed consent
- •Vulnerable subjects will not be recruited
Outcomes
Primary Outcomes
Knowledge Score
Time Frame: Pre-Counsel, 1 day Visit
Via a survey, patients will be asked general questions about kidney masses and their treatments. There are 10 questions, each scored as correct or incorrect (0 or 1), and the last question has 3 sub-components each scored 0-1. The total range of score is 0-10; a score of 10 indicates strongest knowledge on kidney masses/treatments.
Decision Satisfaction Score
Time Frame: Post-Counsel, 1 day Visit
Via a survey, patients provide their opinion on 16 statements. Each statement is scored 1 (strongly disagree) to 5 (strongly agree). The total range of score is 1-80; a higher score indicates higher satisfaction.
Shared Decision Making
Time Frame: Post-Counsel, 1 day Visit
This is a binary outcome measure. Patients will be asked whether or not they felt they participated in a shared decision making process: 0 for no, 1 for yes.